Rosacea
📧 Sign up to get email alerts when something new happens for Rosacea.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-10-14FDA Approved: SOOLANTRA — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for Soolantra (ivermectin) submitted by Galderma Laboratories, L.P., resulting in an approved supple…
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea [Phase 2]
A Phase 2 clinical trial evaluated safety and efficacy of B244 in adults with mild to moderate rosacea; study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle [Phase 3]
Phase 3 study comparing CLS001 topical gel to vehicle in rosacea completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application [Phase 4]
Phase 4 clinical trial assessing whether MetroGel 1% delivers moisture to facial skin after a single application in rosacea patients.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle [Phase 3]
Phase 3 study evaluating safety and efficacy of once-daily CLS001 topical gel for rosacea has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel [Phase 3]
Phase 3 trial assessing long-term safety of once-daily omiganan topical gel for rosacea has completed with results posted in 2022.
-
FDA approval · 2022-07-01FDA Approved: AZELAIC ACID GEL — Supplemental Application (Encube Ethicals, Inc.)
FDA approved a supplemental application for AZELAIC ACID GEL from Encube Ethicals, Inc. under ANDA208724.
-
FDA approval · 2022-04-22FDA Approved: EPSOLAY — Original Application (Galderma Laboratories, L.P.)
FDA approved EPSOLAY (benzoyl peroxide) through an Original Application by Galderma Laboratories, L.P. for the treatment of inflammatory les…
-
FDA approval · 2021-12-15FDA Approved: ORACEA — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for ORACEA (doxycycline) from Galderma Laboratories, L.P.
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea [Phase 4]
Phase 4 trial update evaluating the efficacy of oral minocycline (Solodyn) alone and in combination with azelaic acid (Finacea) for rosacea.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Safety and Efficacy Study of DRM02 in Subjects With Rosacea [Phase 2]
Phase 2 trial assessing safety and efficacy of DRM02 in subjects with rosacea has been completed.
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream" [Phase 3]
Phase 3 clinical endpoint bioequivalence study of Oxymetazoline Hydrochloride Cream completed for rosacea; results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
Clinical trial update evaluating Mirvaso utilization and patient satisfaction for rosacea has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea [Phase 3]
Phase 3 trial evaluating reduction in facial erythema in adults with moderate to severe persistent rosacea; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea [Phase 3]
A Phase 3 comparative trial evaluating two treatments for inflammatory lesions of rosacea has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea [Phase 3]
Phase 3 trial comparing two rosacea products for facial erythema in rosacea; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face [Phase 3]
A Phase 3 bioequivalence study evaluating two treatments for inflammatory facial lesions in rosacea has completed with results posted.
-
FDA approval · 2020-12-01FDA Approved: FINACEA FOAM — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application to add FINACEA FOAM, a topical azelaic acid product from LEO Pharma, for the treatment of Rosacea.
-
FDA approval · 2020-11-27FDA Approved: AZELAIC ACID GEL — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for azelaic acid gel from Sandoz Inc., indicating continued approval and potential label updates.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea [Phase 2]
A Phase 2 double-blind, randomized trial comparing incobotulinumtoxinA to saline injections for rosacea in the cheek region; results posted …
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation. [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating topical ivermectin for reducing inflammatory markers in rosacea; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea [Phase 2]
Phase 2 trial exploring efficacy and tolerability of erenumab for persistent redness and flushing in rosacea.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea [Phase 3]
A Phase 3 trial evaluated the safety and clinical outcomes of azelaic acid gel 15% for moderate facial rosacea; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Clinical Endpoint Study of Ivermectin 1% Cream [Phase 3]
Phase 3 clinical trial of ivermectin 1% cream for moderate to severe papulopustular rosacea completed with results posted.
-
FDA approval · 2020-05-28FDA Approved: ZILXI — Original Application (Journey Medical Corporation)
FDA approved ZILXI (minocycline) from Journey Medical Corporation via an original NDA for the treatment of inflammatory lesions of rosacea.